Literature DB >> 11437283

Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart.

M L Valencik1, J A McDonald.   

Abstract

Tetracycline regulated gene expression in transgenic animals is potentially a very powerful technique (Furth et al., 1994; Gossen & Bujard 1992). We have utilized this system in an attempt to overcome the perinatal lethality resulting from constitutive transgenic expression in the heart (Valencik & McDonald, Am J Physiol Heart Circ Physiol 280: H361-H367). We found that compound hemizygous animals created by mating selected reverse tetracycline transactivator (rtTA) and transresponder (TR) lines display tightly regulated TR expression in the heart. However, we identified two fundamental problems. First, codon usage bias appeared to severely limit the expression of the rtTA driven by the cardiac alpha-myosin heavy chain promoter. Second, co-injection of rtTA and TR transgenes led to compound hemizygous animals that exhibited unregulated TR gene expression. Codon optimization of the rtTA construct leads to marked improvement (increasing the average induction from 20-fold to 832-fold) in cardiac myocyte expression. The resulting opt-rtTA lines can be bred to homozygosity, facilitating rapid screening of F0 TR animals for doxycycline regulated transgene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11437283     DOI: 10.1023/a:1016601928465

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  14 in total

1.  Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch.

Authors:  K D Wells; J A Foster; K Moore; V G Pursel; R J Wall
Journal:  Transgenic Res       Date:  1999-10       Impact factor: 2.788

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  "Cre"-ating mouse mutants-a meeting review on conditional mouse genetics.

Authors:  J Rossant; A McMahon
Journal:  Genes Dev       Date:  1999-01-15       Impact factor: 11.361

4.  Isolation of high molecular weight DNA for reliable genotyping of transgenic mice.

Authors:  M Malumbres; R Mangues; N Ferrer; S Lu; A Pellicer
Journal:  Biotechniques       Date:  1997-06       Impact factor: 1.993

5.  Co-regulation of two gene activities by tetracycline via a bidirectional promoter.

Authors:  U Baron; S Freundlieb; M Gossen; H Bujard
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

6.  Isolation and characterization of the mouse cardiac myosin heavy chain genes.

Authors:  J Gulick; A Subramaniam; J Neumann; J Robbins
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

7.  Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.

Authors:  P A Furth; L St Onge; H Böger; P Gruss; M Gossen; A Kistner; H Bujard; L Hennighausen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

8.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

9.  The Yersinia pseudotuberculosis invasin protein and human fibronectin bind to mutually exclusive sites on the alpha 5 beta 1 integrin receptor.

Authors:  G T Van Nhieu; R R Isberg
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

10.  Isolation and characterization of Chinese hamster ovary cell variants deficient in the expression of fibronectin receptor.

Authors:  C L Schreiner; J S Bauer; Y N Danilov; S Hussein; M M Sczekan; R L Juliano
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  41 in total

Review 1.  Cardiac-specific inducible and conditional gene targeting in mice.

Authors:  Thomas Doetschman; Mohamad Azhar
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

Review 2.  Signaling networks regulating development of the lower respiratory tract.

Authors:  David M Ornitz; Yongjun Yin
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-05-01       Impact factor: 10.005

3.  Cardiac CaV1.2 channels require β subunits for β-adrenergic-mediated modulation but not trafficking.

Authors:  Lin Yang; Alexander Katchman; Jared Kushner; Alexander Kushnir; Sergey I Zakharov; Bi-Xing Chen; Zunaira Shuja; Prakash Subramanyam; Guoxia Liu; Arianne Papa; Daniel Roybal; Geoffrey S Pitt; Henry M Colecraft; Steven O Marx
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

Review 4.  A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.

Authors:  Abdelwahed Chtarto; Olivier Bockstael; Terence Tshibangu; Olivier Dewitte; Marc Levivier; Liliane Tenenbaum
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

5.  Differential Wnt-mediated programming and arrhythmogenesis in right versus left ventricles.

Authors:  Gang Li; Aditi Khandekar; Tiankai Yin; Stephanie C Hicks; Qiusha Guo; Kentaro Takahashi; Catherine E Lipovsky; Brittany D Brumback; Praveen K Rao; Carla J Weinheimer; Stacey L Rentschler
Journal:  J Mol Cell Cardiol       Date:  2018-09-05       Impact factor: 5.000

6.  Inducible, tightly regulated and non-leaky neuronal gene expression in mice.

Authors:  Fabien Delerue; Michael White; Lars M Ittner
Journal:  Transgenic Res       Date:  2013-11-09       Impact factor: 2.788

7.  PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.

Authors:  Guey-Shin Wang; Muge N Kuyumcu-Martinez; Satyam Sarma; Nitin Mathur; Xander H T Wehrens; Thomas A Cooper
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

8.  Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.

Authors:  Misha Koshelev; Satyam Sarma; Roger E Price; Xander H T Wehrens; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2010-01-05       Impact factor: 6.150

9.  Improved Tet-responsive promoters with minimized background expression.

Authors:  Rainer Loew; Niels Heinz; Mathias Hampf; Hermann Bujard; Manfred Gossen
Journal:  BMC Biotechnol       Date:  2010-11-24       Impact factor: 2.563

10.  Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure.

Authors:  Hyoung-gon Lee; Qun Chen; Julie A Wolfram; Sandy L Richardson; Anna Liner; Sandra L Siedlak; Xiongwei Zhu; Nicholas P Ziats; Hisashi Fujioka; Dean W Felsher; Rudy J Castellani; Maria L Valencik; John A McDonald; Brian D Hoit; Edward J Lesnefsky; Mark A Smith
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.